ERBB2 and neoplasm: In a study conducted by Sun-Seog Kweon et al., the highest and the lowest percentage of tumours positive for B7H4 expression was found in HR−/HER2+ and HR+/HER2+ cases—respectively, 60% and 25% [30,33].